SLC1A2 and amyotrophic lateral sclerosis: Initial evidence for astrocytic contribution to motor neuron damage and ALS progression came from studies of decrease and dysfunction of astrocyte glutamate transporter GLT1 (EAAT2 in human) in ALS patients or ALS animal models 16, 17.